At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
HIV-Associated Heart Disease
National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted May 26, 2000·Updated Feb 18, 2016
In Brief
An observational study for Cardiovascular Diseases and 4 related conditions. Completed.
Detailed Summary
To develop natural history data regarding the incidence, clinical course, prognosis, and effects of treatment with anti-viral and immunosuppressive agents on HIV-associated heart disease. A second part of the study evaluated a number of possible mechanisms underlying the development of HIV heart disease.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Myocardial Diseases, Acquired Immunodeficiency Syndrome, HIV Infections
Countries--
Collaborators--
Timeline
N/ACompletedFinished
1988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 1988
Study CompletionJun 1993
First PostedMay 2000
TodayJul 2026
First PostedMay 26, 2000
Enrollment StartJul 1, 1988
Study CompletionJun 1, 1993
TodayJul 2, 2026
Posted 26.1 years ago